Clinically significant bleeding due to chemotherapy-induced thrombocytopenia occurs in <10% of patients with solid tumours. [7] However, thrombocytopenia-related costs can be substantial even in ...
The study population comprised 228 patients whose previous treatment with first-line chemotherapy or at ... therapy in patients with bortezomib-induced thrombocytopenia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback